NPA
IDXX icon

Nichols & Pratt Advisers’s Idexx Laboratories IDXX Stock Holding History

Nichols & Pratt Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526K Hold
1,000
– – 0.03% 78
2026
Q1 		$562K Buy
+1,000
New +$641K 0.04% 74

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Nichols & Pratt Advisers's IDXX Position: Q2 2026 in Review

Nichols & Pratt Advisers held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,000 shares worth $526K. The position accounts for 0.03% of the portfolio, ranked #78.

Nichols & Pratt Advisers first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $562K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Nichols & Pratt Advisers held 1,000 shares of Idexx Laboratories worth $526K as of Q2 2026.
  • Nichols & Pratt Advisers left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.03% of Nichols & Pratt Advisers's portfolio in Q2 2026, its #78 holding.
  • Nichols & Pratt Advisers first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Nichols & Pratt Advisers's Idexx Laboratories position peaked at $562K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.